Surrozen (SRZN) Operating Leases (2020 - 2026)
Surrozen (SRZN) posted quarterly Operating Leases of $4.9 million for Q1 2026, down 28.43% year-over-year from $6.8 million in Q1 2025, and down 9.31% quarter-over-quarter from $5.3 million in Q4 2025.
Surrozen (SRZN) Operating Leases (2020 - 2026) Analysis & Trends
Surrozen's Operating Leases history runs 7 years deep, the most recent figure standing at $4.9 million for Q1 2026.
- In Q1 2026, Operating Leases fell 28.43% year-over-year to $4.9 million; the TTM figure through Mar 2026 stood at $4.9 million (down 28.43% YoY), while the FY2025 annual figure was $5.3 million, down 19.44% from the prior year.
- Operating Leases for Q1 2026 stood at $4.9 million, down from $5.3 million in the prior quarter.
- The five-year high for Operating Leases was $6.8 million in Q1 2025, with the low at $223000.0 in Q1 2024.
- The 5-year median for Operating Leases is $4.5 million (2022), against an average of $4.0 million.
- The sharpest annual moves came in 2024 and 2025: Operating Leases slumped 91.99% in 2024, then surged 2939.46% in 2025.
- Surrozen's Operating Leases stood at $3.4 million in 2022, then plunged by 73.87% to $882000.0 in 2023, then jumped by 652.83% to $6.6 million in 2024, then decreased by 19.44% to $5.3 million in 2025, then retreated by 9.31% to $4.9 million in 2026.
- Business Quant data shows SRZN's Operating Leases at $4.9 million in Q1 2026, $5.3 million in Q4 2025, and $5.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Surrozen | 281.63 Mn | 281.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.33 Mn |
| Mar 31, 2026 | 4.85 Mn |
| Dec 31, 2025 | 5.35 Mn |
| Sep 30, 2025 | 5.84 Mn |
| Jun 30, 2025 | 6.32 Mn |
| Mar 31, 2025 | 6.78 Mn |
| Dec 31, 2024 | 6.64 Mn |
| Mar 31, 2024 | 223,000.00 |
| Dec 31, 2023 | 882,000.00 |
| Sep 30, 2023 | 1.53 Mn |
| Jun 30, 2023 | 2.16 Mn |
| Mar 31, 2023 | 2.78 Mn |
| Dec 31, 2022 | 3.38 Mn |
| Sep 30, 2022 | 3.96 Mn |
| Jun 30, 2022 | 4.53 Mn |
| Mar 31, 2022 | 5.07 Mn |
| Dec 31, 2021 | 5.60 Mn |
| Sep 30, 2021 | 6.06 Mn |
| Dec 31, 2020 | 7.49 Mn |